At Circle Pharma, we're pushing the boundaries of drug discovery by engineering next-generation macrocycle therapeutics to tackle some of cancer's most challenging targets.
GET TO KNOW US
At Circle Pharma, we're pushing the boundaries of drug discovery by engineering next-generation macrocycle therapeutics to tackle some of cancer's most challenging targets.
GET TO KNOW US
At Circle Pharma, we're pushing the boundaries of drug discovery by engineering next-generation macrocycle therapeutics to tackle some of cancer's most challenging targets.
GET TO KNOW US
Powered by our proprietary MXMO™ platform, which combines computationally driven drug design along with advanced, fully synthetic macrocycle chemistry, we’re designing oral, cell-permeable macrocycles to reach important cancer targets beyond the reach of conventional medicines.
The highly selective nature of macrocycles give them the potential to transcend the entire cancer therapy experience, including more comfort and fewer side effects during and after treatment.
Subscribe to our News Alerts